Literature DB >> 22923099

Update on the use and outcomes of implantable cardioverter defibrillators in pediatric patients.

Christian J Turner1, Elizabeth A Stephenson.   

Abstract

OPINION STATEMENT: The vast majority of implantable cardioverter defibrillators (ICDs) continue to be implanted in the adult population. Accordingly, manufacturers develop devices and leads primarily for the adult population. Whilst the number of ICDs implanted in children is small in comparison, the potential benefits are large to this group. It is a common frustration among pediatric cardiologists whom implant devices that impressive technological developments continue to be developed for the adult population; as the population of children with ICDs is small, robust clinical studies often lag behind. By necessity, pediatric cardiologists and cardiothoracic surgeons have developed innovative techniques utilizing adult components in unusual configurations for children with complex congenital heart disease. As in the adult population, inappropriate shocks are one of the most limiting and concerning complications in the use of ICDs. Unfortunately, as will be discussed below, children are at increased risk of inappropriate shocks when compared with adults. The true impact of inappropriate shocks is increasingly being realized, and much of the focus in management of children with ICDs surrounds the prevention of inappropriate shocks.

Entities:  

Year:  2012        PMID: 22923099     DOI: 10.1007/s11936-012-0202-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  42 in total

1.  Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips.

Authors:  Paul Khairy; Fadi Mansour
Journal:  Heart Rhythm       Date:  2010-11-04       Impact factor: 6.343

Review 2.  Current state of the art for use of pacemakers and defibrillators in patients with congenital cardiac malformations.

Authors:  Elizabeth A Stephenson; Jonathan R Kaltman
Journal:  Cardiol Young       Date:  2006-09       Impact factor: 1.093

3.  Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

Authors:  Niraj Varma; Andrew E Epstein; Anand Irimpen; Robert Schweikert; Charles Love
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

4.  Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.

Authors:  Justin M Horner; Masayoshi Kinoshita; Tracy L Webster; Carla M Haglund; Paul A Friedman; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2010-09-17       Impact factor: 6.343

5.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Authors:  M Mirowski; P R Reid; M M Mower; L Watkins; V L Gott; J F Schauble; A Langer; M S Heilman; S A Kolenik; R E Fischell; M L Weisfeldt
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

6.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

7.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

8.  Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).

Authors:  J Siebels; K H Kuck
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

9.  Epidemiology of cardiac arrest and resuscitation in children.

Authors:  M Eisenberg; L Bergner; A Hallstrom
Journal:  Ann Emerg Med       Date:  1983-11       Impact factor: 5.721

10.  Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. The Medtronic Transvene Investigators.

Authors:  J Kron; M J Silka; O J Ohm; G Bardy; D Benditt
Journal:  Pacing Clin Electrophysiol       Date:  1994-01       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.